{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260617001418/en/Corcept-Resubmits-New-Drug-Application-for-Relacorilant-as-a-Treatment-for-Patients-with-Cushing%E2%80%99s-Syndrome", "message": "News view counter 805762 successfully enlarged"}